Zhengye Biotechnology Holding (ZYBT) Loans and Notes Receivables (2023 - 2025)

Historic Loans and Notes Receivables for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to -$13687.0.

  • Zhengye Biotechnology Holding's Loans and Notes Receivables changed N/A to -$13687.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$13687.0, marking a year-over-year change of. This contributed to the annual value of $3.6 million for FY2024, which is 842.24% up from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Loans and Notes Receivables of -$13687.0 as of Q2 2025.
  • Zhengye Biotechnology Holding's 5-year Loans and Notes Receivables high stood at $3.6 million for Q4 2024, and its period low was -$13687.0 during Q2 2025.
  • Moreover, its 3-year median value for Loans and Notes Receivables was $3.2 million (2023), whereas its average is $2.3 million.
  • Within the past 5 years, the most significant YoY rise in Zhengye Biotechnology Holding's Loans and Notes Receivables was 1049.97% (2024), while the steepest drop was 1049.97% (2024).
  • Zhengye Biotechnology Holding's Loans and Notes Receivables (Quarter) stood at $3.2 million in 2023, then grew by 10.5% to $3.6 million in 2024, then crashed by 100.38% to -$13687.0 in 2025.
  • Its last three reported values are -$13687.0 in Q2 2025, $3.6 million for Q4 2024, and $3.2 million during Q4 2023.